Yongshun Biological: Important in research projects to obtain staged results

On July 18, 2022, Yongshun Biological (839729.BJ), a listed company in the Beijing Stock Exchange, issued an announcement of important stages of results in research projects.

The announcement shows that the name of the project in the research project: the development and development of the pig's branched pneumonia vaccine (GD0503) According to the "Regulations on the Management of Veteria" and the "Veterinary Medicine Registration Measures" Referred to as "Company") and the "Pig Branial Pneumonic Pneumonic Vaccine (GD0503)" jointly declared by Guangzhou Boheng Biotechnology Co., Ltd., Yunnan Biopharmaceutical Co., Ltd. and Guangdong Yuyue Biotechnology Co., Ltd. : (2022) New Veterinary Medicine Certificate No. 34.

The new veterinary drug was approved by the clinical trials of veterinary biological products on May 18, 2017. After subsequent clinical trials and new veterinary drug registration, the new veterinary drug registration certificate was issued on July 15, 2022. This product is mainly used to prevent pigscopic pneumonia (pork asthma).

Yongshun Biological said that the acquisition of the new veterinary drug certificate is a manifestation of the company's continuous attention to technological innovation and increased research and development investment. The successful development of this product has further enriched the company's product category, extended market space, and has a positive effect on improving the company's market competitiveness and sustainable development.

It should be noted that in accordance with the relevant provisions such as the "Administrative Measures for the Management of Veterinary Pharmaceuticals" and "Administrative Number of Veterinary Medicine Products", the product approved number of veterinary drug products issued before listing is also obtained.

The company has obtained the approval number of the veterinary drug product and the time for subsequent production and sales. The company will perform the information disclosure obligations in a timely manner in accordance with the provisions and requirements of laws and regulations in accordance with the provisions and requirements of laws and regulations.

- END -